secwatch.observer — SEC 8-K summary
======================================

Issuer:     QuidelOrtho Corp (QDEL)
CIK:        0001906324
Form:       8-K
Filed at:   2025-11-05T23:59:59+00:00
Accession:  0001906324-25-000158
Event type: earnings
Sentiment:  neutral
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

QuidelOrtho Q3 revenue $700M (-4% YoY); GAAP loss $10.78/sh on $701M impairment; Adj EPS $0.80
--------------------------------------------------------------------------------

- Total revenue $700M, down 4% YoY; non-respiratory revenue up 5% as reported, 6% constant currency ex-Donor Screening.
- GAAP net loss $733M includes $701M non-cash goodwill impairment; GAAP diluted EPS loss $10.78; adjusted diluted EPS $0.80.
- Adjusted EBITDA $177M, margin 25%, up 180 bps YoY driven by cost-savings initiatives.
- FY2025 guidance narrowed: revenue $2.68-$2.74B, adjusted EBITDA $585-$605M, adjusted diluted EPS $2.00-$2.15.
- Completed debt refinancing to improve financial flexibility with reduced amortization; terms not detailed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1906324/000190632425000158/0001906324-25-000158-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1906324/000190632425000158/qdel-20251105.htm
  HTML page:      https://secwatch.observer/filing/0001906324-25-000158

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer